Drug interactions
Elafibranor + Rosiglitazone
Severity: Moderate
Elafibranor and Rosiglitazone: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Elafibranor is a PPAR-alpha/delta agonist, and combining it with PPAR-gamma agonists such as rosiglitazone may increase the risk of hepatic injury. Both drugs may also affect fluid balance and liver enzymes.
What this interaction means in plain words
Elafibranor and Rosiglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Elafibranor belongs to Gastrointestinal Tract; Rosiglitazone belongs to Endocrine.
Why it happens
Additive PPAR agonism with overlapping hepatotoxic potential; the exact mechanism is not fully established.
What to do
Monitor liver tests regularly during combined use and stop one agent if liver enzymes or bilirubin rise significantly.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Elafibranor and Rosiglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Elafibranor
- Elafibranor + Gemfibrozil Major
- Elafibranor + Estradiol Moderate
- Elafibranor + Fenofibrate Moderate
- Elafibranor + Pioglitazone Moderate
- Elafibranor + Rifampicin Moderate
- Elafibranor + Levonorgestrel Minor
Other interactions of Rosiglitazone
- Insulin aspart protamine / insulin aspart + Rosiglitazone Major
- Insulin aspart-insulin aspart protamine + Rosiglitazone Major
- Insulin aspart + Rosiglitazone Major
- Insulin degludec / insulin aspart + Rosiglitazone Major
- Insulin degludec-insulin aspart + Rosiglitazone Major
- Insulin degludec-liraglutide + Rosiglitazone Major
Frequently asked questions
Can I take Elafibranor with Rosiglitazone?
MediHelp rates the interaction as moderate. Elafibranor and Rosiglitazone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Elafibranor is a PPAR-alpha/delta agonist, and combining it with PPAR-gamma agonists such as rosiglitazone may increase the risk of hepatic injury. Both drugs may also affect fluid balance and liver enzymes.
How serious is the interaction between Elafibranor and Rosiglitazone?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver tests regularly during combined use and stop one agent if liver enzymes or bilirubin rise significantly.
What other medicines interact with Elafibranor?
MediHelp also lists interactions of Elafibranor with, for example, Gemfibrozil, Estradiol, Fenofibrate. The full list is on the Elafibranor page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
